• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Labs in Court: Two EKRA-Related Cases and Some Usual Suspects

Labs in Court: Two EKRA-Related Cases and Some Usual Suspects

by Danielle Sloane, Morgan Tandy | Oct 28, 2024 | Essential, Lab Industry Advisor, Labs in Court

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
July 2024 Labs in Court

July 2024 Labs in Court

by Morgan Tandy, Danielle Sloane | Jun 24, 2024 | Essential, Lab Industry Advisor, Labs in Court

Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
EKRA 101: A Brief Backgrounder and How to Stay Compliant

EKRA 101: A Brief Backgrounder and How to Stay Compliant

by Tara Cepull, MA | Jun 3, 2024 | Compliance Perspectives-lca, Essential, Lab Industry Advisor

How the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) came to be, what laboratory leaders should know about it, and how to comply

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Tool: Addressing EKRA When Selling Your Lab

Compliance Tool: Addressing EKRA When Selling Your Lab

by Tara Cepull, MA | May 24, 2024 | Essential, Lab Industry Advisor, Tool

Key steps to follow when selling your lab to ensure compliance with the Eliminating Kickbacks in Recovery Act of 2018 (EKRA)

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Why You Need to Address EKRA When Selling Your Lab

Why You Need to Address EKRA When Selling Your Lab

by Tara Cepull, MA | May 24, 2024 | Compliance Perspectives-lca, Essential, Lab Industry Advisor

When selling your laboratory, in order to remain compliant with federal code, EKRA is something you will want to consider

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com